Cipher Pharmaceuticals Inc.
General ticker "CPHRF" information:
- Sector: Health Care
- Industry: Drug Manufacturers - Specialty & Generic
- Capitalization: $251.2M (TTM average)
Cipher Pharmaceuticals Inc. follows the US Stock Market performance with the rate: 49.7%.
Estimated limits based on current volatility of 1.1%: low 10.32$, high 10.55$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [7.72$, 13.29$]
- 2025-12-31 to 2026-12-31 estimated range: [7.27$, 12.63$]
Financial Metrics affecting the CPHRF estimates:
- Positive: with PPE of 21.6 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 23.52 > 18.64
- Negative: negative Industry operating cash flow (median)
- Positive: 6.82 < Operating cash flow per share per price, % of 7.86
- Positive: 41.86 < Shareholder equity ratio, % of 62.98 <= 63.39
- Negative: negative Industry operating income (median)
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.63 > 6.04
Short-term CPHRF quotes
Long-term CPHRF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | $21.16MM | $33.36MM |
| Operating Expenses | $9.63MM | $25.52MM |
| Operating Income | $11.53MM | $7.85MM |
| Non-Operating Income | $1.15MM | $-4.89MM |
| R&D Expense | $0.14MM | $0.00MM |
| Income(Loss) | $12.68MM | $2.96MM |
| Taxes | $-7.70MM | $-8.59MM |
| Profit(Loss)* | $20.38MM | $11.54MM |
| Stockholders Equity | $80.52MM | $102.34MM |
| Inventory | $2.98MM | $5.79MM |
| Assets | $86.03MM | $162.51MM |
| Operating Cash Flow | $16.00MM | $19.55MM |
| Capital expenditure | $0.02MM | $0.04MM |
| Investing Cash Flow | $-0.14MM | $-80.04MM |
| Financing Cash Flow | $-5.24MM | $39.30MM |
| Earnings Per Share** | $0.82 | $0.47 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.